Diagnosis and Treatment of Myeloproliferative Neoplasms With PCM1-JAK2 Rearrangement: Case Report and Literature Review

Myeloproliferative neoplasm (MPN) with PCM1-JAK2 rearrangement is a rare disease with poor prognosis and lacks uniform treatment guidelines. Several studies confirmed the efficacy of ruxolitinib in hematological malignancies with PCM1-JAK2 fusion, but the efficacy is variable. Here, we report two pa...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Yingxin Sun, Yifeng Cai, Jia Chen, Jiannong Cen, Mingqing Zhu, Jinlan Pan, Depei Wu, Aining Sun, Suning Chen
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2021-10-01
Serie:	Frontiers in Oncology
Soggetti:	myeloproliferative neoplasms PCM1-JAK2 ruxolitinib pegylated interferon case report
Accesso online:	https://www.frontiersin.org/articles/10.3389/fonc.2021.753842/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!